Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes

NCT01630369 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
552
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi